|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7088 | |
| C07H 21/02 | |||
| A61K 48/00 | |||
| A61K 31/7115 | |||
| A61K 31/713 | |||
| C12N 15/113 | |||
| A61P 27/02 |
| (11) | Patento numeris | 3329924 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17187246.8 |
| Europos patento paraiškos padavimo data | 2011-03-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 318702 P | 2010-03-29 | US | |
| 318704 P | 2010-03-29 | US |
| (72) |
ALVAREZ, Rene, US
SAH, Dinah Wen-Yee, US
ANDO, Yukio, JP
JONO, Hirofumi, JP
|
| (73) |
Kumamoto University,
39-1 Kurokami 2-chome, Kumamoto-shi Kumamoto 860-8555,
JP
Alnylam Pharmaceuticals, Inc., 300 Third Street, 3rd Floor, Cambridge, MA 02142, US |
| (54) | DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS |
| DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS |